Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 000020291 approvals45 trials

DONGWHA PHARM.CO.,LTD

Official website

Dongwha Pharm, founded in 1897 and KOSPI-listed in 1976, is a diversified company centered on pharmaceuticals.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1897 and listed on KOSPI in 1976, Dongwha Pharm is a diversified company centered on pharmaceuticals. Alongside pharmaceuticals, it operates a medical device manufacturing and sales business, a pharmaceutical distribution chain, and a smaller financial business, and holds a 62.07% stake in medical device maker Medicei Co., Ltd. as its intermediate holding company. In its 97th fiscal period, consolidated revenue was KRW 496.4 billion, up 6.78% year over year, while operating profit fell 98.09% year over year to KRW 256 million.

Regulatory approvals

data.go.kr

286 Korean MFDS drug approvals · 1957–2026 / 5 Korean MFDS device approvals · 2018–2021

  • MFDS drugWHALCAB Tab. 10mg (vonoprazan)2026-08-12
    Drug · Prescription · Approval202602348
  • MFDS drugWHALCAB Tab. 20mg (vonoprazan)2026-08-12
    Drug · Prescription · Approval202602349
  • MFDS drugFlofena Soft Cap2026-08-10
    Drug · OTC · Notification202602325
  • MFDS drugPanlong Solution2026-08-10
    Drug · OTC · Notification202602326
  • MFDS drugWhituben Kids Cough Syrup2026-07-13
    Drug · OTC · Notification202602015
  • MFDS drugWhituben Kids Cold Syrup2026-06-10
    Drug · OTC · Notification202601644
  • MFDS drugPravafen Cap.2026-05-29
    Drug · Prescription · Approval202601574
  • MFDS drugK21 Tab. 50mg(Tegoprazan)2026-04-30
    Drug · Prescription · Approval202601289
  • MFDS drugK21 Tab. 25mg(Tegoprazan)2026-04-30
    Drug · Prescription · Approval202601291
  • MFDS drugBibicom solution2026-04-15
    Drug · OTC · Notification202601091
  • MFDS drugNEWVI-LA-BAEL Tablets2025-12-24
    Drug · OTC · Notification202503381
  • MFDS drugRebapin SR Tablet 150mg2025-10-15
    Drug · Prescription · Approval202502662
Show 68 more
  • MFDS drugMagnetar SoftCap.2025-10-14
    Drug · OTC · Notification202502651
  • MFDS drugECCLOCK gel, 5% (Sofpironium Bromide)2025-08-29
    Drug · Prescription · Approval202502275
  • MFDS drugLacto Fresh Tab.2025-07-29
    Drug · OTC · Notification202501960
  • MFDS drugWhituben Kidsfen Syrup2025-06-23
    Drug · OTC · Notification202501547
  • MFDS drugAripico Tab. 2mg2025-06-17
    Drug · Prescription · Approval202501473
  • MFDS drugAripico Tab. 1mg2025-06-12
    Drug · Prescription · Approval202501444
  • MFDS drugPancold A Oral Liquid 30mL2025-05-28
    Drug · OTC · Notification202501327
  • MFDS drugEmfldiem Met XR tab. 10/1000mg2025-04-24
    Drug · Prescription · Approval202500992
  • MFDS drugEmfldiem Met XR tab. 25/1000mg2025-04-24
    Drug · Prescription · Approval202500993
  • MFDS drugVI-LA-BAEL essen Tablets2025-03-17
    Drug · OTC · Notification202500584
  • MFDS drugPANCOLD-H Dry Syrup2025-03-17
    Drug · OTC · Notification202500588
  • MFDS drugDongwha Nicergoline Tab. 10mg(Nicergoline)2025-03-05
    Drug · Prescription · Approval202500496
  • MFDS drugPOWERCOL-NoseQ Soft Capsules2025-01-20
    Drug · OTC · Notification202500153
  • MFDS drugAlbothyl Gargle Solution(benzydamine hydrochloride)2025-01-17
    Drug · OTC · Notification202500139
  • MFDS drugDongwha Memantine tablets 20mg(memantine hydrochloride)2025-01-16
    Drug · Prescription · Approval202500125
  • MFDS drugDongwha Hangsim Tab. 240mg2024-11-15
    Drug · OTC · Notification202402697
  • MFDS drugWhituben S Nasal Spray2024-10-31
    Drug · OTC · Notification202402577
  • MFDS drugComakitenQ Nasal Spray2024-08-13
    Drug · OTC · Notification202401972
  • MFDS drugDongwha Quetiapine tablet 12.5mg2024-07-24
    Drug · Prescription · Approval202401795
  • MFDS drugWhituben Nose Syrup2024-05-29
    Drug · OTC · Notification202401331
  • MFDS drugWhituben Cold Syrup2024-05-28
    Drug · OTC · Notification202401314
  • MFDS drugWhituben Cough Syrup2024-05-27
    Drug · OTC · Notification202401290
  • MFDS drugDongwha Albothyl sol.(Policresulen 50% solution)2024-05-20
    Drug · OTC · Notification202401206
  • MFDS drugPANCOLD Care Solutions2024-03-06
    Drug · OTC · Notification202400486
  • MFDS drugLinaDiem Met. XR tab. 5/1000mg2024-02-22
    Drug · Prescription · Approval202400383
  • MFDS drugLinaDiem Met. XR tab. 2.5/1000mg2024-02-22
    Drug · Prescription · Approval202400388
  • MFDS drugDongwha Nicergoline Tab. 30mg(Nicergoline)2024-02-08
    Drug · Prescription · Approval202400304
  • MFDS drugV100QGOLD Tab.Revoked2024-01-08
    Drug · OTC · Notification202400052
  • MFDS drugVI-LA-BAEL-ED Tablets2023-12-19
    Drug · OTC · Notification202303365
  • MFDS drugVI-LA-BAEL-UP Tablets2023-12-06
    Drug · OTC · Notification202303291
  • MFDS drugEmfldiem Met Tab. 12.5/850mg2023-09-05
    Drug · Prescription · Approval202302633
  • MFDS drugEmfldiem Met Tab. 12.5/1000 mg2023-09-05
    Drug · Prescription · Approval202302635
  • MFDS drugEmfldiem Met Tab. 12.5/500 mgRevoked2023-09-05
    Drug · Prescription · Approval202302634
  • MFDS drugFOXIFLE DUO XR TAB. 10/500 mgRevoked2023-06-21
    Drug · Prescription · Approval202301899
  • MFDS drugDryan liquid(aluminum chloride)2023-05-30
    Drug · OTC · Notification202301701
  • MFDS drugDasidiem Tab.10/100 mg (dapagliflozin,sitagliptin)2023-05-16
    Drug · Prescription · Approval202301577
  • MFDS drugWHAL MATE Tablets2023-04-11
    Drug · OTC · Notification202301185
  • MFDS drugDafldiem Met XR Tab. 10/500mg2023-01-31
    Drug · Prescription · Approval202300430
  • MFDS drugDafldiem Met XR Tab. 10/1000mg2023-01-31
    Drug · Prescription · Approval202300431
  • MFDS drugWhituben Q Plus Soft Cap.2023-01-06
    Drug · OTC · Notification202300071
  • MFDS drugWhituben Q Plus nose Soft Cap.2023-01-06
    Drug · OTC · Notification202300078
  • MFDS drugFOXIFLE DUO XR TAB. 10/1000 mgRevoked2023-01-06
    Drug · Prescription · Approval202300148
  • MFDS drugWhituben Q Plus cough Soft Cap.2023-01-02
    Drug · OTC · Notification202300008
  • MFDS drugSitDeim Met tab.50/500mg2022-12-21
    Drug · Prescription · Approval202204588
  • MFDS drugSitDeim Met tab.50/850mg2022-12-21
    Drug · Prescription · Approval202204589
  • MFDS drugSitDeim Met tab.50/1000mg2022-12-21
    Drug · Prescription · Approval202204590
  • MFDS drugBu-Chae Pyo Shib Ccin Tang2022-08-26
    Drug · OTC · Notification202203395
  • MFDS drugSitdiem Met XR Tab. 50/1000 mg2022-05-10
    Drug · Prescription · Approval202201898
  • MFDS drugSitdiem Met XR Tab. 100/1000mg2022-05-10
    Drug · Prescription · Approval202201899
  • MFDS drugSitdiem Met XR Tab. 50/500mg2022-05-10
    Drug · Prescription · Approval202201900
  • MFDS drugEmfldiem Met Tab. 5/850 mgRevoked2022-04-22
    Drug · Prescription · Approval202201662
  • MFDS drugEmfldiem Met Tab. 5/500 mgRevoked2022-04-22
    Drug · Prescription · Approval202201663
  • MFDS drugEmfldiem Met Tab. 5/1000 mgRevoked2022-04-22
    Drug · Prescription · Approval202201664
  • MFDS drugTediem Met XR Tab. 10/500 mg2022-04-04
    Drug · Prescription · Approval202201435
  • MFDS drugTediem Met XR Tab. 20/1000 mg2022-04-04
    Drug · Prescription · Approval202201436
  • MFDS drugTediem Met XR Tab. 10/750 mg2022-04-04
    Drug · Prescription · Approval202201437
  • MFDS drugBargio Once Solution2022-02-09
    Drug · OTC · Notification202200638
  • MFDS drugRABEDUET Tab. 20/500mg2022-01-27
    Drug · Prescription · Approval202200475
  • MFDS drugRABEDUET Tab. 10/500mg(Rabeprazole Sodium, Sodium Bicarbonate)2021-12-31
    Drug · Prescription · Approval202108210
  • MFDS drugWHAL MATE Tablets2021-12-30
    Drug · OTC · Notification202108193
  • MFDSDressing, fluid-impermeable film2021-12-16
    Product approval · Class 2제인 21-5046 호
  • MFDSDressing, fluid-impermeable film2021-12-16
    Product approval · Class 2제인 21-5045 호
  • MFDS drugRivacor tab. 2.5mg(Rivaroxaban)Revoked2021-08-27
    Drug · Prescription · Approval202106198
  • MFDS drugSOGAFTEN Tab.2021-07-07
    Drug · OTC · Notification202105133
  • MFDSDressing, fluid-impermeable film2021-06-16
    Product approval · Class 2제인 21-4525 호
  • MFDS drugTediem tab. 20mg2021-04-20
    Drug · Prescription · Approval202103223
  • MFDS drugEmfldiem Tab. 25 mg2021-03-16
    Drug · Prescription · Approval202102363
  • MFDS drugEmfldiem Tab. 10 mg2021-03-16
    Drug · Prescription · Approval202102364

Showing the 80 most recent of 291 records.

Clinical trials

data.go.kr

45 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 20 · Phase 1 19 · Phase 2 2 · Phase 3 2 · Phase 2a 1)

  • Phase 1DW60252026-05-26

    1 trial site

  • BioequivalenceDW6018B 25mg2024-09-23

    1 trial site

  • BioequivalenceDW6018B 25mg2024-09-20

    1 trial site

  • BioequivalenceDW6019정 60 mg2024-05-28

    1 trial site

  • BioequivalenceDW60182024-02-19

    1 trial site

  • BioequivalenceDW60182024-02-06

    1 trial site

  • BioequivalenceDW60172023-07-21

    1 trial site

  • BioequivalenceDW51082023-02-27

    1 trial site

  • Phase 1DW60142023-02-14

    1 trial site

  • Phase 1DW60142022-11-01

    1 trial site

  • Phase 1DW60132022-06-10

    1 trial site

  • Phase 1DW60132022-04-04

    1 trial site

Show 33 more
  • Phase 1DW60122021-07-13

    1 trial site

  • Phase 2DW2008S2020-11-23

    10 trial sites

  • Phase 2DW2008S2020-06-04
  • BioequivalenceDW5266(리바록사반20밀리그램)2020-03-17

    2 trial sites

  • Phase 1DW60082019-12-16

    2 trial sites

  • BioequivalenceDW5268(에제티미브/아토르바스타틴 10/40밀리그램)2019-09-06

    2 trial sites

  • BioequivalenceDW5266(리바록사반20밀리그램)2019-06-21

    2 trial sites

  • Phase 3자보란테정2018-11-07

    19 trial sites

  • Phase 1DW20052018-04-27

    1 trial site

  • Phase 1DW2008S2018-02-26

    2 trial sites

  • Phase 1DW60092018-01-10

    1 trial site

  • Phase 1DW60102017-04-10

    1 trial site

  • Phase 1DW60082017-02-07

    1 trial site

  • Phase 1다코젠주2016-11-29

    3 trial sites

  • Phase 2aDW2007정2016-06-07

    8 trial sites

  • Bioequivalence돈페질정23밀리그램2015-12-03

    2 trial sites

  • Bioequivalence동화바레니클린정1밀리그램(가칭)2015-11-25

    2 trial sites

  • Bioequivalence디에스오정40밀리그램(Esomeprazole magnesium dihydrate43.38mg (Esomeprazole로서 40mg))2015-06-30

    2 trial sites

  • Phase 1DW1029M건조엑스2014-09-24

    1 trial site

  • Bioequivalence스타넵틴정2014-09-19

    2 trial sites

  • Phase 1DW1029M건조엑스2014-08-25

    1 trial site

  • Phase 1DW1029M건조엑스2014-08-25

    1 trial site

  • Phase 1자보란테정2014-05-30

    1 trial site

  • Bioequivalence에탈로프정10밀리그램(에스시탈로프람옥살산염)2013-12-27

    2 trial sites

  • Phase 1DW1029M건조엑스2013-10-18

    1 trial site

  • Phase 2bDW1029M건조엑스2013-04-19

    10 trial sites

  • Bioequivalence메녹틸정(옥틸로늄브롬화물)(변경허가 후)2013-03-22

    2 trial sites

  • Bioequivalence동화세레콕시브캡슐200밀리그램2013-03-21

    2 trial sites

  • Bioequivalence동화로수바스타틴정10밀리그램2013-02-06

    2 trial sites

  • Bioequivalence동화아리피프라졸10밀리그램2012-07-27

    2 trial sites

  • Bioequivalence판토프라정40밀리그람2012-07-18

    2 trial sites

  • Phase 3자보란테정2012-07-16

    35 trial sites

  • Phase 1DWCZP정100밀리그램2012-06-11

    6 trial sites

AI reads

MAA server logs · IP-verified
1
Read to answer a question

Someone asked an AI a question, and it fetched this page live to answer.

0
Crawled for indexing

Collected for later use. Not a signal of interest.

1answer
index 0
Last 7 days
1answer
index 0
Last 30 days
1answer
index 0
All time
  • OpenAIChatGPT-Useranswer1

Measured since Aug 25, 2026 · 1 AI engines · last read Aug 25, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.

Connect this index to your AI tool →

Not yet compiled: business overview · products · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

DongKookPharmaceuticalCo.,Ltd.3 shared

KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.

BNC KOREA, Inc.2 shared

Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.

HANS BIOMED CORPORATION2 shared

KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.

Humedix Co., Ltd.2 shared

KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.

PharmaResearch Co., Ltd.2 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

Wonbiogen Co.,Ltd.2 shared

Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.

BIO-FD&C CO.,LTD.1 shared

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

BioPlus Co., Ltd1 shared

Founded in 2003 and KOSDAQ-listed in 2021, BioPlus develops HA-based bio medical devices and biopharmaceuticals using its proprietary MDM Technology platform.

DaehanPharmaceutical1 shared

Daehan Pharmaceutical, founded in 1963 and KOSDAQ-listed in 1994, manufactures intravenous fluid pharmaceuticals.

GC Biopharma Corp.1 shared

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

GC Medical Science Corporation1 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Hanmi Science Co.,Ltd1 shared

KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition